Journal of Renal Nutrition
Volume 19, Issue 3 , Pages 238-247 , May 2009

Nutritional and Inflammatory Status of Hemodialysis Patients in Relation to Their Body Mass Index

  • Ilia Beberashvili, MD

      Affiliations

    • Division of Nephrology, Assaf Harofeh Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
    • Corresponding Author InformationAddress reprint requests to Ilia Beberashvili, MD, Division of Nephrology, Assaf Harofeh Medical Center, Zerifin 70300, Israel.
    • ,
  • Inna Sinuani, PhD

      Affiliations

    • Division of Nephrology, Assaf Harofeh Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
    • ,
  • Ada Azar, BSc

      Affiliations

    • Department of Nutrition, Assaf Harofeh Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
    • ,
  • Hila Yasur, BSc

      Affiliations

    • Department of Nutrition, Assaf Harofeh Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
    • ,
  • Leonid Feldman, MD

      Affiliations

    • Division of Nephrology, Assaf Harofeh Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
    • ,
  • Shai Efrati, MD

      Affiliations

    • Division of Nephrology, Assaf Harofeh Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
    • ,
  • Zhan Averbukh, MD, PhD

      Affiliations

    • Division of Nephrology, Assaf Harofeh Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
    • ,
  • Joshua Weissgarten, MD

      Affiliations

    • Division of Nephrology, Assaf Harofeh Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel

Received 19 May 2008

References 

  1. Salahudeen AK. Obesity and survival on dialysis. Am J Kidney Dis. 2003;41:925–932
  2. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81:543–554
  3. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis. 2005;46:489–500
  4. Warnberg J, Nova E, Moreno LA, et al. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr. 2006;84:505–512
  5. Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. 2006;69:29–35
  6. De Vinuesa SG, Goicoechea M, Kanter J, et al. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade. J Am Soc Nephrol. 2006;17(Suppl):S206–S212
  7. Bologa RM, Levine DM, Parker TS, et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis. 1998;32:107–114
  8. Stenvinkel P, Barany P, Heimburger O, et al. Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6?. Kidney Int. 2002;80(Suppl):S103–S108
  9. Rao M, Guo D, Perianayagam MC, et al. Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2005;45:324–333
  10. Zoccali C, Tripepi G, Mallamaci F. Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients?. J Am Soc Nephrol. 2006;17(Suppl):S169–S173
  11. Heimburger O, Lonnqvist F, Danielsson A, et al. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol. 1997;8:1423–1430
  12. Merabet E, Dagogo-Jack S, Coyne DW, et al. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab. 1997;82:847–850
  13. Nordfors L, Lonnqvist F, Heimburger O, Danielsson A, Schalling M, Stenvinkel P. Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int. 1998;54:1267–1275
  14. Don BR, Rosales LM, Levine NW, Mitch W, Kaysen GA. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int. 2001;59:1114–1120
  15. Ottonello L, Gnerre P, Bertolotto M, et al. Leptin as a uremic toxin interferes with neutrophil chemotaxis. J Am Soc Nephrol. 2004;15:2366–2372
  16. National Institutes of Health . Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6(Suppl):S51–S20
  17. Chertow GM, Lowrie EG, Wilmore DW, et al. Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients. J Am Soc Nephrol. 1995;6:75–81
  18. Chertow GM, Lazarus JM, Lew NL, et al. Bioimpedance norms for the hemodialysis population. Kidney Int. 1997;52:1617–1621
  19. Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int. 1999;56:1136–1148
  20. Johansen KL, Young B, Kaysen GA, Chertow GM. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr. 1999;80:324–332
  21. Fleischmann E, Teal N, Dudley J, et al. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int. 1999;55:1560–1567
  22. Salahudeen AK, Fleischmann EH, Bower JD. Impact of lower delivered Kt/V on the survival of overweight patients on hemodialysis. Kidney Int. 1999;56:2254–2259
  23. Pifer TB, McCullough KP, Port FK, et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int. 2002;62:2238–2245
  24. Ohkawa S, Odamaki M, Ikegaya N, et al. Association of age with muscle mass, fat mass and fat distribution in non-diabetic haemodialysis patients. Nephrol Dial Transplant. 2005;20:945–951
  25. Nelson EE, Hong CD, Pesce AL, et al. Anthropometric norms for the dialysis population. Am J Kidney Dis. 1990;16:32–37
  26. Cano NJ, Roth H, Aparicio M, et al. French Study Group for Nutrition in Dialysis (FSG-ND). Malnutrition in hemodialysis diabetic patients: evaluation and prognostic influence. Kidney Int. 2002;62:593–601
  27. Maggiore Q, Nigrelli S, Ciccarelli C, Grimaldi C, Rossi GA, Michelassi C. Nutritional and prognostic correlates of bioimpedance indexes in hemodialysis patients. Kidney Int. 1996;50:2103–2108
  28. Chertow GM, Jacobs DO, Lazarus J, et al. Phase angle predicts survival in hemodialysis patients. J Ren Nutr. 1997;4:204–207
  29. Beddhu S, Cheung AK, Larive B, et al. Hemodialysis (HEMO) Study Group. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr. 2007;17:372–380
  30. Kahraman S, Yilmaz R, Akinci D, et al. U-shaped association of body mass index with inflammation and atherosclerosis in hemodialysis patients. J Ren Nutr. 2005;15:377–386
  31. Kimmel PL, Chawla LS, Amarasinghe A, et al. Anthropometric measures, cytokines and survival in haemodialysis patients. Nephrol Dial Transplant. 2003;18:326–332
  32. Panichi V, Migliori M, De Pietro S, et al. Plasma C-reactive protein in hemodialysis patients: a cross-sectional, longitudinal clinical survey. Blood Purif. 2000;18:30–36
  33. Kaizu Y, Kimura M, Yoneyama T, Miyaji K, Hibi I, Kumagai H. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis. 1998;31:93–100
  34. Axelsson J, Qureshi AR, Suliman ME, et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr. 2004;80:1222–1229
  35. Heimburger O, Wang T, Lonnqvist F, et al. Peritoneal clearance of leptin in CAPD patients: impact of local insulin administration. Nephrol Dial Transplant. 1999;14:723–727
  36. Coyne DW, Dagogo-Jack S, Klein S, et al. High-flux dialysis lowers plasma leptin concentration in chronic dialysis patients. Am J Kidney Dis. 1998;32:1031–1035
  37. Yannakoulia M, Yiannakouris N, Bluher S, et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab. 2003;88:1730–1736
  38. Johansen KL, Mulligan K, Tal V, Schambelan M. Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol. 1998;9:1080–1084
  39. Pecoits-Filho R, Nordfors L, Heimburger O, et al. Soluble leptin receptors and serum leptin in end-stage renal disease: relationship with inflammation and body composition. Eur J Clin Invest. 2002;32:811–817
  40. Koo JR, Pak KY, Kim KH, et al. The relationship between plasma leptin and nutritional status in chronic hemodialysis patients. J Korean Med Sci. 1999;14:546–551
  41. Rammohan M, Kalantar-Zadeh K, Liang A, Ghossein C. Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. J Ren Nutr. 2005;15:345–355
  42. Sinha MK, Opentanova I, Ohannesian JP, et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest. 1997;98:1277–1282

PII: S1051-2276(08)00464-0

doi: 10.1053/j.jrn.2008.11.007

Journal of Renal Nutrition
Volume 19, Issue 3 , Pages 238-247 , May 2009

Article Tools

* Image Usage & Resolution